Free certificates of participation are available upon successful completion of a learning quiz at: http://www.classmarker.com/online-test/start/?quiz=t665357ea6247811
Published: 04/23/2014 Length: 00:51:05
Dr. Fasano completed his medical training at the University of Naples in Italy, and in 1993 he founded the University of Maryland School of Medicine’s Division of Pediatric Gastroenterology and Nutrition. Ten years later, Dr. Fasano published the groundbreaking study in the Annals of Medicine that established the prevalence rate of celiac disease at one in 133 people in the U.S. In 1996 Dr. Fasano founded the Center for Celiac Research, the first celiac center in the United States, which is currently located at MassGeneral Hospital for Children. Clinical and research work at the Center has helped to identify the new disorder of non-celiac gluten sensitivity as a condition on the spectrum of gluten-related disorders. Dr. Fasano leads a team of researchers across nine countries and enjoys research partnerships with institutions around the world. He has published more than 200 peer-reviewed papers and he has received numerous awards for his translational science and other achievements. Dr. Fasano has been named one of America’s Top Doctors by Castle Connolly for five consecutive years (2007-2011) and was a 2005 finalist for the NIH Director’s Pioneer Award. In the year 2000 Dr. Fasano’s team discovered “zonulin,” the molecule which regulates intestinal permeability, also known as “leaky gut”, and their totally ground-breaking research has linked an overproduction of zonulin to the development of a series of autoimmune diseases, including type 1 diabetes, celiac disease and multiple sclerosis.
Upcoming Webinar: 03/04/2020, 1 PM - 2:00 PM Eastern Time (US) Tune in to learn about research exploring the role enteric neurotransmitters, specifically serotonin and oxytocin, play in enteric nervous system (ENS) development
A 2019 study from the University of Missouri adds to evidence that behavior problems in children with autism spectrum disorders (ASD) can be an indication of gastrointestinal (GI)
10/2/2019 - A study from the University of Missouri adds to evidence that behavior problems in children with autism spectrum disorders (ASD) can be an indication of gastrointestinal (GI) distress. Bradley Ferguson
Many studies have reported abnormal gut microbiota in individuals with Autism Spectrum Disorders (ASD), suggesting a link between gut microbiome and autism-like behaviors. Modifying the gut microbiome is